{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:37:54Z","timestamp":1790728674340,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1704500"],"award-info":[{"award-number":["2018YFC1704500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111326","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T06:50:17Z","timestamp":1612594217000},"page":"111326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["New insight and potential therapy for NAFLD: CYP2E1 and flavonoids"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-0654","authenticated-orcid":false,"given":"Kaiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangxiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0911-1714","authenticated-orcid":false,"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2021.111326_bib0005","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3748\/wjg.v22.i8.2483","article-title":"Glycosyltransferases and non-alcoholic fatty liver disease","volume":"22","author":"Zhan","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111326_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: a novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Yu","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0015","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hep.27680","article-title":"Nonalcoholic fatty liver disease: fibrosis portends a worse prognosis","volume":"61","author":"Torres","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2021.111326_bib0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","article-title":"Nonalcoholic fatty future disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2021.111326_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.biopha.2021.111326_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0035","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u2019\u2019?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009871","article-title":"New molecular mechanism underlying myc-mediated cytochrome P450 2E1 upregulation in apoptosis and energy metabolism in the myocardium","volume":"8","author":"Guan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2021.111326_bib0045","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopha.2017.11.043","article-title":"A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells","volume":"97","author":"Jian","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111326_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.phytochem.2013.03.024","article-title":"Classification of flavonoid compounds by using entropy of information theory","volume":"93","author":"Castellano","year":"2013","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10408398.2012.656770","article-title":"Flavonoids and immune function in human: a systematic review","volume":"55","author":"Peluso","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"30","key":"10.1016\/j.biopha.2021.111326_bib0060","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","article-title":"Herbal medicines and nonalcoholic fatty liver disease","volume":"22","author":"Yao","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111326_bib0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jep.2014.08.044","article-title":"Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction","volume":"156","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0070","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.foodchem.2013.05.019","article-title":"Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats","volume":"141","author":"Zhang","year":"2013","journal-title":"Food Chem."},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103005","article-title":"Hepatoprotective effect of loquat leaf flavonoids in PM2.5-induced non-alcoholic fatty liver disease via regulation of IRs-1\/Akt and CYP2E1\/JNK pathways","volume":"19","author":"Jian","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0080","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.3390\/ijms15057352","article-title":"Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)","volume":"15","author":"Takaki","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.111326_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"Ter Horst","year":"2017","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.biopha.2021.111326_bib0090","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0095","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MOL.0000000000000427","article-title":"Interpreting lipoproteins in nonalcoholic fatty liver disease","volume":"28","author":"Nemes","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0105","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/jhep.2002.32527","article-title":"Apolipoprotein synthesis in nonalcoholic steatohepatitis","volume":"35","author":"Charlton","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/jhep.2003.50290","article-title":"Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis","volume":"38","author":"Sreekumar","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111326_bib0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0125","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0035-1550065","article-title":"Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications","volume":"35","author":"Angulo","year":"2015","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bpg.2011.02.011","article-title":"Anti-fibrogenic strategies and the regression of fibrosis","volume":"25","author":"Kisseleva","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0140","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2002.32995","article-title":"Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat","volume":"122","author":"Ikejima","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0145","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/jhep.2002.32029","article-title":"Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob\/ob mice","volume":"35","author":"Saxena","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0150","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-291X(02)02300-8","article-title":"Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation","volume":"297","author":"Tang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","article-title":"Leptin is essential for the hepatic fibrogenic response to chronic liver injury","volume":"37","author":"Leclercq","year":"2002","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.22978","article-title":"Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.biopha.2021.111326_bib0165","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2174\/1381612824666180410091511","article-title":"Cytochrome P450s and alcoholic liver disease","volume":"24","author":"Lu","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2021.111326_bib0170","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2013.09.009","article-title":"CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis","volume":"65","author":"Abdelmegeed","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111326_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.redox.2014.09.004","article-title":"Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling","volume":"3","author":"Schattenberg","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.111326_bib0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-94-007-5881-0_5","article-title":"Relevance of CYP2E1 to non-alcoholic fatty liver disease","volume":"67","author":"Daly","year":"2013","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.biopha.2021.111326_bib0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2015.12.020","article-title":"A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: application to acetaminophen","volume":"292","author":"Michaut","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20080868","article-title":"High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo","volume":"417","author":"Mantena","year":"2009","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.biopha.2021.111326_bib0195","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","article-title":"From fatty liver to fibrosis: a tale of \"second hit\"","volume":"19","author":"Basaranoglu","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111326_bib0200","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/MEG.0b013e328328f461","article-title":"Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease","volume":"21","author":"Kathirvel","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111326_bib0205","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1074\/jbc.M410310200","article-title":"Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling","volume":"280","author":"Schattenberg","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","article-title":"Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis","volume":"57","author":"Abdelmegeed","year":"2012","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.biocel.2011.06.010","article-title":"The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis","volume":"43","author":"Lee","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.yexmp.2015.11.008","article-title":"Induction of CYP2E1 in non-alcoholic fatty liver diseases","volume":"99","author":"Aljomah","year":"2015","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111326_bib0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.fct.2014.04.042","article-title":"Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin","volume":"70","author":"Vornoli","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111326_bib0235","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5650\/jos.ess19018","article-title":"Hepatoprotective effect of seed coat of euryale ferox extract in non-alcoholic fatty liver disease induced by high-fat diet in mice by increasing IRs-1 and inhibiting CYP2E1","volume":"68","author":"Jian","year":"2019","journal-title":"J. Oleo Sci."},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2021.111326_bib0240","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111326_bib0245","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0250","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111326_bib0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrfmmm.2004.04.021","article-title":"Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1","volume":"569","author":"Gonzalez","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2021.111326_bib0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2018.03.170","article-title":"Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction","volume":"104","author":"Zhao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111326_bib0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.intimp.2017.05.035","article-title":"Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling","volume":"49","author":"Afrin","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"47","key":"10.1016\/j.biopha.2021.111326_bib0270","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of alcoholic liver disease: role of oxidative metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111326_bib0275","first-page":"1","article-title":"Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450-452E1-mediated oxidative and nitrative stress","volume":"0","author":"Cho","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111326_bib0280","doi-asserted-by":"crossref","first-page":"39764","DOI":"10.1038\/srep39764","article-title":"Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis","volume":"7","author":"Abdelmegeed","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111326_bib0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2015.12.016","article-title":"Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress","volume":"91","author":"Abdelmegeed","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0290","article-title":"High fat diet induces fibrosis in mice lacking CYP2A5 and PPAR\u03b1: a new model for steatohepatitis-associated fibrosis","volume":"319","author":"A.-M.G. Chen","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111326_bib0295","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1074\/jbc.M110506200","article-title":"Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells","volume":"277","author":"Nieto","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1874467208666150817111114","article-title":"Role of CYP2E1 in mitochondrial dysfunction and hepatic injury by alcohol and non-alcoholic substances","volume":"10","author":"Abdelmegeed","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111326_bib0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jnutbio.2016.08.013","article-title":"Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice","volume":"38","author":"Choi","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2009.07.016","article-title":"Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity","volume":"79","author":"Abdelmegeed","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111326_bib0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108918","article-title":"The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis","volume":"316","author":"Seitz","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0320","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/hep.22087","article-title":"Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice","volume":"47","author":"Wu","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111326_bib0325","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejphar.2014.06.006","article-title":"Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats","volume":"738","author":"Xin","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111326_bib0330","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0024-3205(00)00809-2","article-title":"Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL\/6J mice","volume":"67","author":"Ueng","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.111326_bib0335","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2017.12.026","article-title":"Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways","volume":"98","author":"Zhong","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111326_bib0340","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4820414","article-title":"Baicalin ameliorates liver injury induced by chronic plus binge ethanol feeding by modulating oxidative stress and inflammation via CYP2E1 and NRF2 in mice","volume":"2017","author":"He","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0345","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1081\/IPH-120026443","article-title":"Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice","volume":"25","author":"Jang","year":"2003","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2021.111326_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2019.02.014","article-title":"Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes","volume":"302","author":"Pingili","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0355","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/alcalc\/agr038","article-title":"Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities","volume":"46","author":"Tahir","year":"2011","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.biopha.2021.111326_bib0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbi.2017.08.006","article-title":"Apigenin protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPAR\u03b1-mediated lipogenic gene expression","volume":"275","author":"Wang","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0365","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.intimp.2013.08.019","article-title":"Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1\/PI3K\/Akt pathway","volume":"17","author":"Zhang","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111326_bib0370","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ptr.1000","article-title":"Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities","volume":"16","author":"Zuber","year":"2002","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2009.10.004","article-title":"Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma","volume":"291","author":"Brandon-Warner","year":"2010","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.biopha.2021.111326_bib0380","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1007\/s10620-018-5268-0","article-title":"Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the Nf-kappaB pathway","volume":"63","author":"Ou","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2021.111326_bib0385","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.biopha.2018.09.089","article-title":"Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells","volume":"108","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0390","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2021.111326_bib0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lfs.2016.06.001","article-title":"Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress","volume":"157","author":"Xie","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.111326_bib0400","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial","volume":"99","author":"Chen","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0405","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1080\/13880209.2017.1339284","article-title":"In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes","volume":"55","author":"Liu","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2021.111326_bib0410","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.intimp.2017.05.026","article-title":"Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries","volume":"49","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0415","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.tiv.2013.01.014","article-title":"Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells","volume":"27","author":"Vidyashankar","year":"2013","journal-title":"Toxicol. In Vitro"},{"issue":"6","key":"10.1016\/j.biopha.2021.111326_bib0420","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.pharep.2017.05.020","article-title":"Quercetin prevents type 1 diabetic liver damage through inhibition of CYP2E1","volume":"69","author":"Maksymchuk","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"19","key":"10.1016\/j.biopha.2021.111326_bib0425","first-page":"2736","article-title":"Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH)","volume":"18","author":"Surapaneni","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2021.111326_bib0430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111326_bib0435","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21060738","article-title":"Effects of flavonoids in Lysimachia clethroides Duby on the activities of cytochrome P450 CYP2E1 and CYP3A4 in rat liver microsomes","volume":"21","author":"Zhang","year":"2016","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2021.111326_bib0440","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1142\/S0192415X1850057X","article-title":"Kaempferol\u2019s protective effect on ethanol-induced mouse primary hepatocytes injury involved in the synchronous inhibition of SP1, Hsp70 and CYP2E1","volume":"46","author":"Zhou","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0445","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1142\/S0192415X15500160","article-title":"Hepatoprotective effect of kaempferol against alcoholic liver injury in mice","volume":"43","author":"Wang","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111326_bib0450","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2018.03.024","article-title":"Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice","volume":"290","author":"Tsai","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2021.111326_bib0455","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinre.2016.07.001","article-title":"Non-alcoholic fatty liver disease and flavonoids: current perspectives","volume":"41","author":"Shin","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111326_bib0460","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1440-1746.2006.04681.x","article-title":"Preventive role of genistein in an experimental non-alcoholic steatohepatitis model","volume":"22","author":"Yalniz","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111326_bib0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.toxlet.2012.12.014","article-title":"Protective effect of genistein isolated from Hydrocotyle sibthorpioides on hepatic injury and fibrosis induced by chronic alcohol in rats","volume":"217","author":"Huang","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2021.111326_bib0470","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/00498254.2016.1195028","article-title":"Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities","volume":"47","author":"Kopecna-Zapletalova","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2021.111326_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.111027","article-title":"CYPs-mediated drug-drug interactions on psoralidin, isobavachalcone, neobavaisoflavone and daidzein in rats liver microsomes","volume":"136","author":"Shi","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0480","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.phymed.2013.04.001","article-title":"Puerarin improves metabolic function leading to hepatoprotective effects in chronic alcohol-induced liver injury in rats","volume":"20","author":"Chen","year":"2013","journal-title":"Phytomedicine"},{"issue":"38","key":"10.1016\/j.biopha.2021.111326_bib0485","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1021\/acs.jafc.6b02907","article-title":"Protective effects of genistein and puerarin against chronic alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms","volume":"64","author":"Zhao","year":"2016","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0490","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/BF02980272","article-title":"Protective effects of puerarin on carbon tetrachloride-lnduced hepatotoxicity","volume":"30","author":"Yong Pil Hwang","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2021.111326_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2018.09.001","article-title":"Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress","volume":"54","author":"Caro","year":"2019","journal-title":"Toxicol. In Vitro"},{"issue":"10","key":"10.1016\/j.biopha.2021.111326_bib0500","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.fct.2007.03.017","article-title":"In vitro protection of reactive oxygen species-induced degradation of lipids, proteins and 2-deoxyribose by tea catechins","volume":"45","author":"Raza","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"8 Pt 2","key":"10.1016\/j.biopha.2021.111326_bib0505","first-page":"e465","article-title":"Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet","volume":"23","author":"Kuzu","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111326_bib0510","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.taap.2005.01.004","article-title":"Green tea polyphenol epigallocatechin-3-gallate differentially modulates oxidative stress in PC12 cell compartments","volume":"207","author":"Raza","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:22:57Z","timestamp":1760098977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":102,"alternative-id":["S0753332221001116"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111326","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insight and potential therapy for NAFLD: CYP2E1 and flavonoids","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111326"}}